Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Terminated 2Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Carcinoma, Non-Small-Cell Lung 2Delirium 1

Interventions

Cyclophosphamide 241Radiotherapy 217Gemcitabine 187Cisplatin 185Carboplatin 182Docetaxel 166Bevacizumab 166Paclitaxel 144Capecitabine 142Rituximab 141pembrolizumab 140Nivolumab 126Oxaliplatin 124Dexamethasone 122Fluorouracil 113fludarabine 104Radiosurgery 101Doxorubicin 99fludarabine phosphate 97Irinotecan 96Etoposide 95Lenalidomide 93Cytarabine 92Magnetic Resonance Spectroscopy 90Radiation 89Filgrastim 89Leucovorin 88Bortezomib 86Cetuximab 80Pemetrexed 79

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Terminated × OTHER × flurbiprofen axetil × Clear all
NCT03200600 2021-07-13

Dexamethasone, Flurbiprofen Axetil and Delirium After Lung Cancer Surgery

Peking University First Hospital

Phase 4 Terminated
126 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Delirium

NCT03172988 2019-03-05

Dexamethasone, Flurbiprofen Axetil and Long-term Survival After Lung Cancer Surgery

Peking University First Hospital

Phase 4 Terminated
126 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡